Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 6109 to 6116 of 6116 entries
Sorted by: Best Match Show Resources per page
Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy.

Thoracic cancer

Xu R, Zhao M, Zhao Y, Xuan Y, Qin Y, Jiao W.
PMID: 34405556
Thorac Cancer. 2021 Oct;12(20):2819-2821. doi: 10.1111/1759-7714.14116. Epub 2021 Aug 18.

Video-assisted thoracoscopic surgery (VATS) subsegmentectomy has been widely used to resect small-sized lung lesions in clinical practice. Precise identification of the subsegmental bronchus is one of the essential steps in performing thoracoscopic anatomic subsegmentectomy. Here, we report a thoracoscopic...

Cite
Xu R, Zhao M, Zhao Y, et al. Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy. Thorac Cancer. 2021;12(20):2819-2821doi: 10.1111/1759-7714.14116.
Xu, R., Zhao, M., Zhao, Y., Xuan, Y., Qin, Y., & Jiao, W. (2021). Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy. Thoracic cancer, 12(20), 2819-2821. https://doi.org/10.1111/1759-7714.14116
Xu, Rongjian, et al. "Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy." Thoracic cancer vol. 12,20 (2021): 2819-2821. doi: https://doi.org/10.1111/1759-7714.14116
Xu R, Zhao M, Zhao Y, Xuan Y, Qin Y, Jiao W. Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy. Thorac Cancer. 2021 Oct;12(20):2819-2821. doi: 10.1111/1759-7714.14116. Epub 2021 Aug 18. PMID: 34405556; PMCID: PMC8520799.
Copy Download .nbib Format: NLM
Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients.

Neuropsychiatric disease and treatment

Xing Y, Fu S, Li M, Ma X, Liu M, Liu X, Huang Y, Xu G, Jiao Y, Wu H, Jiang G, Tian J.
PMID: 34429605
Neuropsychiatr Dis Treat. 2021 Aug 17;17:2697-2706. doi: 10.2147/NDT.S323127. eCollection 2021.

PURPOSE: The aim of this study was to compare regional homogeneity (ReHo) changes in Parkinson's disease mild cognitive impairment (PD-MCI) patients with respect to normal controls (NC) and those with cognitively normal PD (PD-CN). Further, the study investigated the...

Cite
Xing Y, Fu S, Li M, et al. Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients. Neuropsychiatr Dis Treat. 2021;17:2697-2706doi: 10.2147/NDT.S323127.
Xing, Y., Fu, S., Li, M., Ma, X., Liu, M., Liu, X., Huang, Y., Xu, G., Jiao, Y., Wu, H., Jiang, G., & Tian, J. (2021). Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients. Neuropsychiatric disease and treatment, 172697-2706. https://doi.org/10.2147/NDT.S323127
Xing, Yilan, et al. "Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients." Neuropsychiatric disease and treatment vol. 17 (2021): 2697-2706. doi: https://doi.org/10.2147/NDT.S323127
Xing Y, Fu S, Li M, Ma X, Liu M, Liu X, Huang Y, Xu G, Jiao Y, Wu H, Jiang G, Tian J. Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients. Neuropsychiatr Dis Treat. 2021 Aug 17;17:2697-2706. doi: 10.2147/NDT.S323127. eCollection 2021. PMID: 34429605; PMCID: PMC8380131.
Copy Download .nbib Format: NLM
Comparison of activation behavior of Cs-O and Cs-NF.

Journal of colloid and interface science

Li S, Zhang Y, Zhang K, Zhang J, Zhan J, Shi F, Jiao G, Cheng H, Feng C.
PMID: 35032772
J Colloid Interface Sci. 2022 Jan 07;613:117-125. doi: 10.1016/j.jcis.2022.01.013. Epub 2022 Jan 07.

To clarify the performance differences between Cs-O and Cs-NF

Cite
Li S, Zhang Y, Zhang K, et al. Comparison of activation behavior of Cs-O and Cs-NF. J Colloid Interface Sci. 2022;613:117-125doi: 10.1016/j.jcis.2022.01.013.
Li, S., Zhang, Y., Zhang, K., Zhang, J., Zhan, J., Shi, F., Jiao, G., Cheng, H., & Feng, C. (2022). Comparison of activation behavior of Cs-O and Cs-NF. Journal of colloid and interface science, 613117-125. https://doi.org/10.1016/j.jcis.2022.01.013
Li, Shan, et al. "Comparison of activation behavior of Cs-O and Cs-NF." Journal of colloid and interface science vol. 613 (2022): 117-125. doi: https://doi.org/10.1016/j.jcis.2022.01.013
Li S, Zhang Y, Zhang K, Zhang J, Zhan J, Shi F, Jiao G, Cheng H, Feng C. Comparison of activation behavior of Cs-O and Cs-NF. J Colloid Interface Sci. 2022 Jan 07;613:117-125. doi: 10.1016/j.jcis.2022.01.013. Epub 2022 Jan 07. PMID: 35032772.
Copy Download .nbib Format: NLM
Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi.

Scientific reports

Cui D, Yan F, Yi J, He D, Zhang Y, Zhang Z, Chen Y, Jiao Y, Zhang B.
PMID: 35013371
Sci Rep. 2022 Jan 10;12(1):417. doi: 10.1038/s41598-021-03851-2.

This study evaluated the efficacy and safety of 3D printing technology combined with percutaneous nephrolithotomy in the treatment of complex renal calculi. Ninety patients with complex renal calculi were randomly divided into a 3D printing group (45 patients) and...

Cite
Cui D, Yan F, Yi J, et al. Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi. Sci Rep. 2022;12(1):417doi: 10.1038/s41598-021-03851-2.
Cui, D., Yan, F., Yi, J., He, D., Zhang, Y., Zhang, Z., Chen, Y., Jiao, Y., & Zhang, B. (2022). Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi. Scientific reports, 12(1), 417. https://doi.org/10.1038/s41598-021-03851-2
Cui, Dong, et al. "Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi." Scientific reports vol. 12,1 (2022): 417. doi: https://doi.org/10.1038/s41598-021-03851-2
Cui D, Yan F, Yi J, He D, Zhang Y, Zhang Z, Chen Y, Jiao Y, Zhang B. Efficacy and safety of 3D printing-assisted percutaneous nephrolithotomy in complex renal calculi. Sci Rep. 2022 Jan 10;12(1):417. doi: 10.1038/s41598-021-03851-2. PMID: 35013371; PMCID: PMC8748774.
Copy Download .nbib Format: NLM
Facile Synthesis of a Fully Fused, Three-Dimensional π-Conjugated Archimedean Cage with Magnetically Shielded Cavity.

Journal of the American Chemical Society

Zhu J, Han Y, Ni Y, Wu S, Zhang Q, Jiao T, Li Z, Wu J.
PMID: 34455792
J Am Chem Soc. 2021 Sep 08;143(35):14314-14321. doi: 10.1021/jacs.1c06490. Epub 2021 Aug 29.

The synthesis of molecular cages consisting of fully fused, π-conjugated rings is rare due to synthetic challenges including preorganization, large strain, and poor solubility. Herein, we report such an example in which a tris-2-aminobenzophenone precursor undergoes acid-mediated self-condensation to...

Cite
Zhu J, Han Y, Ni Y, et al. Facile Synthesis of a Fully Fused, Three-Dimensional π-Conjugated Archimedean Cage with Magnetically Shielded Cavity. J Am Chem Soc. 2021;143(35):14314-14321doi: 10.1021/jacs.1c06490.
Zhu, J., Han, Y., Ni, Y., Wu, S., Zhang, Q., Jiao, T., Li, Z., & Wu, J. (2021). Facile Synthesis of a Fully Fused, Three-Dimensional π-Conjugated Archimedean Cage with Magnetically Shielded Cavity. Journal of the American Chemical Society, 143(35), 14314-14321. https://doi.org/10.1021/jacs.1c06490
Zhu, Jun, et al. "Facile Synthesis of a Fully Fused, Three-Dimensional π-Conjugated Archimedean Cage with Magnetically Shielded Cavity." Journal of the American Chemical Society vol. 143,35 (2021): 14314-14321. doi: https://doi.org/10.1021/jacs.1c06490
Zhu J, Han Y, Ni Y, Wu S, Zhang Q, Jiao T, Li Z, Wu J. Facile Synthesis of a Fully Fused, Three-Dimensional π-Conjugated Archimedean Cage with Magnetically Shielded Cavity. J Am Chem Soc. 2021 Sep 08;143(35):14314-14321. doi: 10.1021/jacs.1c06490. Epub 2021 Aug 29. PMID: 34455792.
Copy Download .nbib Format: NLM
Incorporating redox-sensitive nanogels into bioabsorbable nanofibrous membrane to acquire ROS-balance capacity for skin regeneration.

Bioactive materials

Zhang S, Li Y, Qiu X, Jiao A, Luo W, Lin X, Zhang X, Zhang Z, Hong J, Cai P, Zhang Y, Wu Y, Gao J, Liu C, Li Y.
PMID: 33817421
Bioact Mater. 2021 Mar 21;6(10):3461-3472. doi: 10.1016/j.bioactmat.2021.03.009. eCollection 2021 Oct.

Facing the high incidence of skin diseases, it is urgent to develop functional materials with high bioactivity for wound healing, where reactive oxygen species (ROS) play an important role in the wound healing process mainly

Cite
Zhang S, Li Y, Qiu X, et al. Incorporating redox-sensitive nanogels into bioabsorbable nanofibrous membrane to acquire ROS-balance capacity for skin regeneration. Bioact Mater. 2021;6(10):3461-3472doi: 10.1016/j.bioactmat.2021.03.009.
Zhang, S., Li, Y., Qiu, X., Jiao, A., Luo, W., Lin, X., Zhang, X., Zhang, Z., Hong, J., Cai, P., Zhang, Y., Wu, Y., Gao, J., Liu, C., & Li, Y. (2021). Incorporating redox-sensitive nanogels into bioabsorbable nanofibrous membrane to acquire ROS-balance capacity for skin regeneration. Bioactive materials, 6(10), 3461-3472. https://doi.org/10.1016/j.bioactmat.2021.03.009
Zhang, Shihao, et al. "Incorporating redox-sensitive nanogels into bioabsorbable nanofibrous membrane to acquire ROS-balance capacity for skin regeneration." Bioactive materials vol. 6,10 (2021): 3461-3472. doi: https://doi.org/10.1016/j.bioactmat.2021.03.009
Zhang S, Li Y, Qiu X, Jiao A, Luo W, Lin X, Zhang X, Zhang Z, Hong J, Cai P, Zhang Y, Wu Y, Gao J, Liu C, Li Y. Incorporating redox-sensitive nanogels into bioabsorbable nanofibrous membrane to acquire ROS-balance capacity for skin regeneration. Bioact Mater. 2021 Mar 21;6(10):3461-3472. doi: 10.1016/j.bioactmat.2021.03.009. eCollection 2021 Oct. PMID: 33817421; PMCID: PMC7988352.
Copy Download .nbib Format: NLM
TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway.

Annals of translational medicine

Yang H, Luo F, Wei Y, Jiao Y, Qian J, Chen S, Gong Y, Tang L.
PMID: 34430599
Ann Transl Med. 2021 Jul;9(14):1158. doi: 10.21037/atm-21-2631.

BACKGROUND: Characterized by the presence of inflammation, fibrosis, and bile duct proliferation, cholestatic liver disease (CLD) affects people of all age groups. Takeda G-protein-coupled receptor (TGR5) has been implicated in the suppression of inflammation via toll-like receptor 4 (TLR4)...

Cite
Yang H, Luo F, Wei Y, et al. TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway. Ann Transl Med. 2021;9(14):1158doi: 10.21037/atm-21-2631.
Yang, H., Luo, F., Wei, Y., Jiao, Y., Qian, J., Chen, S., Gong, Y., & Tang, L. (2021). TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway. Annals of translational medicine, 9(14), 1158. https://doi.org/10.21037/atm-21-2631
Yang, Haojun, et al. "TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway." Annals of translational medicine vol. 9,14 (2021): 1158. doi: https://doi.org/10.21037/atm-21-2631
Yang H, Luo F, Wei Y, Jiao Y, Qian J, Chen S, Gong Y, Tang L. TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway. Ann Transl Med. 2021 Jul;9(14):1158. doi: 10.21037/atm-21-2631. PMID: 34430599; PMCID: PMC8350648.
Copy Download .nbib Format: NLM
Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy.

Bioengineered

Lu Y, Ma J, Lin J, Tian Y, Ma Y, Wang W, Li J, Zhang H, Jiao P.
PMID: 34898368
Bioengineered. 2021 Dec;12(2):12708-12721. doi: 10.1080/21655979.2021.2010314.

Liver cancer is an aggressive malignancy with exhibits both high mortality and morbidity. The current treatment options are associated with several limitations, novel specific anti-cancer drugs are urgently needed to improve liver cancer treatment. In this study, a new...

Cite
Lu Y, Ma J, Lin J, et al. Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy. Bioengineered. 2021;12(2):12708-12721doi: 10.1080/21655979.2021.2010314.
Lu, Y., Ma, J., Lin, J., Tian, Y., Ma, Y., Wang, W., Li, J., Zhang, H., & Jiao, P. (2021). Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy. Bioengineered, 12(2), 12708-12721. https://doi.org/10.1080/21655979.2021.2010314
Lu, Yuanhua, et al. "Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy." Bioengineered vol. 12,2 (2021): 12708-12721. doi: https://doi.org/10.1080/21655979.2021.2010314
Lu Y, Ma J, Lin J, Tian Y, Ma Y, Wang W, Li J, Zhang H, Jiao P. Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy. Bioengineered. 2021 Dec;12(2):12708-12721. doi: 10.1080/21655979.2021.2010314. PMID: 34898368.
Copy Download .nbib Format: NLM
Showing 6109 to 6116 of 6116 entries